Effect of oral pancreatic enzyme administration on digestive function in healthy subjects: Comparison between two enzyme preparations

被引:13
作者
DominguezMunoz, JE
Birckelbach, U
Glasbrenner, B
Sauerbruch, T
Malfertheiner, P
机构
[1] OTTO VON GUERICKE UNIV,KLIN GASTROENTEROL,DEPT GASTROENTEROL,D-39120 MAGDEBURG,GERMANY
[2] UNIV BONN,DEPT INTERNAL MED,D-5300 BONN,GERMANY
[3] UNIV ULM,DEPT INTERNAL MED,D-7900 ULM,GERMANY
关键词
D O I
10.1046/j.1365-2036.1997.143319000.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Intraduodenal proteases exert a negative feedback on pancreatic secretion. Aim: To investigate the effect of two pancreatic enzyme preparations (enteric-coated tablets, and capsules with enteric-coated microtablets) on postprandial pancreatic and bile acid secretion, gastroduodenal motility and release of gastrin and pancreatic polypeptide in healthy humans. Methods: Twenty healthy males were studied on two different days one week apart. After an overnight fast a nine-lumen motility tube was positioned with the distal tip at the Treitz angle. On each study day, 30 min after an interdigestive migrating motor complex-phase III, a semi-liquid test meal was given either alone (n = 20) or with enzymes (3 tablets (n = 10) or 2 capsules with microtablets (n = 10); 40000 U lipase and 2000 proteases) in a randomized order, and the study continued over 2 h, Motility was continuously recorded with four ports in the antrum and three in the duodenum, using a low-compliance pneumohydraulic perfusion system. Secretion of human-specific pancreatic elastase and bile acids was measured by a standard duodenal intubation perfusion technique. Plasma concentrations of gastrin and pancreatic polypeptide were measured by specific radioimmunoassays. Results: Postprandial pancreatic secretion was significantly reduced by administration of microtablets (median 82 mg/2 h vs. 70 mg/2 h, P < 0.02) but not by tablets (median 59 mg/2 h vs, 58 mg/2 h, N,S.). No changes were observed in bile acid secretion, antroduodenal motility or release of gastrin and pancreatic polypeptide. Conclusions: Oral administration of pancreatic enzymes at normal therapeutic doses significantly inhibits postprandial pancreatic secretion in healthy humans, when capsules with enteric-coated microtablets are given, Exogenous pancreatic enzymes have no significant effect on bile acid secretion, gastroduodenal motility and hormone release.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 29 条
[1]   DIFFERENTIAL-EFFECTS OF ATROPINE AND A CHOLECYSTOKININ RECEPTOR ANTAGONIST ON PANCREATIC-SECRETION [J].
ADLER, G ;
REINSHAGEN, M ;
KOOP, I ;
GOKE, B ;
SCHAFMAYER, A ;
ROVATI, LC ;
ARNOLD, R .
GASTROENTEROLOGY, 1989, 96 (04) :1158-1164
[2]   STIMULATION OF PANCREATIC-SECRETION IN MAN BY A PROTEASE INHIBITOR (CAMOSTATE) [J].
ADLER, G ;
MULLENHOFF, A ;
KOOP, I ;
BOZKURT, T ;
GOKE, B ;
BEGLINGER, C ;
ARNOLD, R .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (01) :98-104
[3]  
FEUERLE GE, 1983, REGUL PEPTIDES, V7, P127
[4]  
FOLSCH UR, 1987, GASTROENTEROLOGY, V92, P449
[5]  
GO VLW, 1970, GASTROENTEROLOGY, V58, P321
[6]   SYMPTOMATIC EFFECT OF PANCREATIC-ENZYME THERAPY IN PATIENTS WITH CHRONIC-PANCREATITIS [J].
HALGREEN, H ;
PEDERSEN, NT ;
WORNING, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 (01) :104-108
[7]   FEEDBACK REGULATION OF PANCREATIC-ENZYME SECRETION BY INTESTINAL TRYPSIN IN MAN [J].
IHSE, I ;
LILJA, P ;
LUNDQUIST, I .
DIGESTION, 1977, 15 (04) :303-308
[8]  
IHSE I, 1991, PANCREATIC ENZYMES H, P89
[9]  
IHSE I, 1979, SCAND J GASTROENTERO, V13, P873
[10]   PAIN REDUCTION BY AN ORAL PANCREATIC-ENZYME PREPARATION IN CHRONIC-PANCREATITIS [J].
ISAKSSON, G ;
IHSE, I .
DIGESTIVE DISEASES AND SCIENCES, 1983, 28 (02) :97-102